Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interventional, Non-comparative, Single-center Post Marketing Clinical Follow-up (PMCF) Study to Evaluate Performance and Safety of "LUXIDROPIN BABY & JUNIOR" Used to Facilitate the Removal of Ocular Secretions in Pediatric Subjects

NCT05855486 is registered in ClinicalTrials.gov with C.O.C. Farmaceutici S.r.l. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05855486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interventional, Non-comparative, Single-center Post Marketing Clinical Follow-up (PMCF) Study to Evaluate Performance and Safety of "LUXIDROPIN BABY & JUNIOR" Used to Facilitate the Removal of Ocular Secretions in Pediatric Subjects
Lead sponsor
C.O.C. Farmaceutici S.r.l.
Phase
Not applicable
Overall status
Completed
Start date
October 12, 2022
Completion date
March 23, 2023
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ocular discharge